Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan-Feb;25(1):69-72.
doi: 10.4103/ijem.ijem_122_21. Epub 2021 Jul 21.

A Perplexing Presentation of SLE as Adrenal Insufficiency in a Young Male

Payal Bargujar  1 , Hans Raj Pahadiya  2
Affiliations

A Perplexing Presentation of SLE as Adrenal Insufficiency in a Young Male

Payal Bargujar et al. Indian J Endocrinol Metab. 2021 Jan-Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Hahn BH. Systemic lupus erythematosus. In: Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, editors. Harrison's Principles of Internal Medicine. 20th ed. New York: Mc Graw-Hill Education; 2018. pp. 2515–22.
    1. Arlt W. Disorders of adrenal cortex. In: Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, editors. Harrison's Principles of Internal Medicine. 20th ed. Vol. 379. New York: Mc Graw-Hill Education; 2018. pp. 2733–34.
    1. Bhat RA, Khan I, Mir T, Khan I, Wani M. Systemic lupus erythematosus presenting as acute adrenal insufficiency: A rare clinical presentation. Ann Med Health Sci Res. 2014;4:140–2. - PMC - PubMed
    1. Rodriguez-Jimenez NA, Perez-Guerrero EE, Gamez-Nava JI, Sanchez-Mosco DI, Saldaña-Cruz AM, Alcaraz-Lopez MF, et al. Anti-nucleosome antibodies increase the risk of renal relapse in a prospective cohort of patients with clinically inactive systemic lupus erythematosus. Sci Rep. 2020;10:12698. - PMC - PubMed
    1. Li T, Prokopec SD, Morrison S, Lou W, Reich H, Gladman D, et al. Anti-nucleosome antibodies outperform traditional biomarkers as longitudinal indicators of disease activity in systemic lupus erythematosus. Rheumatology (Oxford) 2015;54:449–57. - PMC - PubMed